Biocartis has announced that it has combined its Swiss Evalution business unit with Belgian-based Pronota NV to jointly form MyCartis. MyCartis also completed an EUR 15 million equity round. Biocartis ...
MyCartis today announced the launch of Evalution™, a multiplex biomarker analysis platform for the life sciences research market. Evalution™ is MyCartis' digital multiplex analysis platform tailored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results